feed,title,long_url,short_url
Benzinga,RedHill Biopharma Expands Opaganib Global COVID-19 Study To US,https://benzinga.com/general/biotech/21/02/19794087/redhill-biopharma-expands-opaganib-global-covid-19-study-to-us,
Benzinga,Protalix's PRXâ€“102 Monthly Treatment Shows Benefit In Fabry Disease,https://benzinga.com/general/biotech/21/02/19793313/protalixs-prx-102-monthly-treatment-shows-benefit-in-fabry-disease,
